Pliant Therapeutics Inc (PLRX)
11.81
-0.07
(-0.59%)
USD |
NASDAQ |
Apr 26, 16:00
11.81
0.00 (0.00%)
After-Hours: 18:18
Pliant Therapeutics Enterprise Value: 231.45M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 231.45M |
| April 24, 2024 | 232.66M |
| April 23, 2024 | 270.00M |
| April 22, 2024 | 274.82M |
| April 19, 2024 | 270.00M |
| April 18, 2024 | 250.12M |
| April 17, 2024 | 290.49M |
| April 16, 2024 | 314.58M |
| April 15, 2024 | 332.05M |
| April 12, 2024 | 368.19M |
| April 11, 2024 | 387.47M |
| April 10, 2024 | 368.19M |
| April 09, 2024 | 414.58M |
| April 08, 2024 | 402.53M |
| April 05, 2024 | 398.31M |
| April 04, 2024 | 392.29M |
| April 03, 2024 | 385.06M |
| April 02, 2024 | 400.12M |
| April 01, 2024 | 407.95M |
| March 28, 2024 | 413.37M |
| March 27, 2024 | 392.29M |
| March 26, 2024 | 367.59M |
| March 25, 2024 | 380.84M |
| March 22, 2024 | 398.31M |
| March 21, 2024 | 429.04M |
| Date | Value |
|---|---|
| March 20, 2024 | 413.37M |
| March 19, 2024 | 401.33M |
| March 18, 2024 | 395.30M |
| March 15, 2024 | 430.84M |
| March 14, 2024 | 413.37M |
| March 13, 2024 | 442.29M |
| March 12, 2024 | 427.83M |
| March 11, 2024 | 391.08M |
| March 08, 2024 | 452.53M |
| March 07, 2024 | 457.95M |
| March 06, 2024 | 460.36M |
| March 05, 2024 | 492.89M |
| March 04, 2024 | 503.13M |
| March 01, 2024 | 512.17M |
| February 29, 2024 | 471.81M |
| February 28, 2024 | 516.98M |
| February 27, 2024 | 552.53M |
| February 26, 2024 | 516.38M |
| February 23, 2024 | 505.54M |
| February 22, 2024 | 473.35M |
| February 21, 2024 | 465.56M |
| February 20, 2024 | 447.58M |
| February 16, 2024 | 512.89M |
| February 15, 2024 | 522.48M |
| February 14, 2024 | 514.69M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-29.62M
Minimum
May 11 2022
1.729B
Maximum
Jan 31 2023
592.45M
Average
560.92M
Median
Enterprise Value Benchmarks
| Masimo Corp | 7.899B |
| Liquidia Corp | 856.78M |
| Vor Biopharma Inc | -21.29M |
| CEL-SCI Corp | 75.03M |
| AIM ImmunoTech Inc | 7.904M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -41.11M |
| Total Expenses (Quarterly) | 47.04M |
| EPS Diluted (Quarterly) | -0.69 |
| Earnings Yield | -23.37% |
| Normalized Earnings Yield | -23.20 |